These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33993805)

  • 21. [Serum pepsinogen I/II ratio test].
    Miki K
    Nihon Rinsho; 2003 Jan; 61(1):92-5. PubMed ID: 12607323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area.
    Chapelle N; Petryszyn P; Blin J; Leroy M; Le Berre-Scoul C; Jirka I; Neunlist M; Moussata D; Lamarque D; Olivier R; Tougeron D; Mosnier JF; Matysiak-Budnik T
    Helicobacter; 2020 Oct; 25(5):e12727. PubMed ID: 32700438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of screening for gastric cancer using serum pepsinogen concentrations.
    Kitahara F; Kobayashi K; Sato T; Kojima Y; Araki T; Fujino MA
    Gut; 1999 May; 44(5):693-7. PubMed ID: 10205207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.
    Huang Z; Zhang X; Lu H; Wu L; Wang D; Zhang Q; Ding H
    BMC Gastroenterol; 2014 Apr; 14():74. PubMed ID: 24720760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decrease of serum total ghrelin in extensive atrophic gastritis: comparison with pepsinogens in histological reference.
    Eun Bae S; Hoon Lee J; Soo Park Y; Ok Kim S; Young Choi J; Yong Ahn J; Hoon Kim D; Don Choi K; June Song H; Hyug Lee G; Choe J; Jin Jang S; Jung HY
    Scand J Gastroenterol; 2016; 51(2):137-44. PubMed ID: 26513345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pepsinogen and gastrin in the noninvasive diagnosis of gastric atrophy. A case-control study in Peruvian population].
    Colarossi A; Inga R; Prochazka R; Reyes U; Bussalleu A; Barúa RL
    Rev Gastroenterol Peru; 2011; 31(2):110-5. PubMed ID: 21836650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of group D patients with negative serum anti-Helicobacter pylori antibody and positive serum pepsinogen test in healthy Koreans.
    Han YM; Chung SJ; Choi JM; Lee C; Kim JS
    J Dig Dis; 2018 Sep; 19(9):529-539. PubMed ID: 30117281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based study.
    Sjomina O; Pavlova J; Daugule I; Janovic P; Kikuste I; Vanags A; Tolmanis I; Rudzite D; Polaka I; Kojalo I; Liepniece-Karele I; Isajevs S; Santare D; Pirags V; Pahomova J; Dzerve V; Tzivian L; Erglis A; Leja M
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):11-17. PubMed ID: 29557410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis.
    Kim EH; Kang H; Park CH; Choi HS; Jung DH; Chung H; Park JC; Shin SK; Lee SK; Lee YC
    Dig Liver Dis; 2015 Aug; 47(8):663-8. PubMed ID: 26077884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.
    Yu G; Wang GX; Wang HG; Mo FF; Tang BB
    Neoplasma; 2019 Jul; 66(4):637-640. PubMed ID: 31058531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
    Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Moreno L; Martín de Argila C
    Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.
    Aikou S; Ohmoto Y; Gunji T; Matsuhashi N; Ohtsu H; Miura H; Kubota K; Yamagata Y; Seto Y; Nakajima A; Goldenring JR; Kaminishi M; Nomura S
    Gastroenterology; 2011 Sep; 141(3):837-845.e1-7. PubMed ID: 21699780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are the serum biomarkers pepsinogen I and II good predictors for the detection of subjects with atrophic gastritis in areas that have different gastric cancer incidence?
    Mohamadkhani A; Darvish Moghaddam S; Salmanroghani H; Allafsghari A; Yazdanbod A; Mirzaei M; Haj-sheykholeslami A; Bashiri J; Sadjadi A; Massarrat S
    Arch Iran Med; 2013 Apr; 16(4):208-12. PubMed ID: 23496362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance in combined detection of serum pepsinogen I, pepsinogen II and carbohydrate antigen 242 in gastric cancer.
    Yun L; Bin Z; Guangqi G; Ding L; Xingdang L; Biao H
    Hepatogastroenterology; 2014; 61(129):255-8. PubMed ID: 24895832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical utility of serum pepsinogen levels as a screening test of atrophic gastritis].
    Chae H; Lee JH; Lim J; Kim M; Kim Y; Han K; Kang CS; Shim SI; Kim JI; Park SH
    Korean J Lab Med; 2008 Jun; 28(3):201-6. PubMed ID: 18594172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori.
    Haneda M; Kato M; Ishigaki S; Suzuki M; Takahashi M; Nakagawa M; Ono S; Mori Y; Mabe K; Nakagawa S; Kudo T; Shimizu Y; Asaka M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.
    So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM
    Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Potentialities of a serological method in diagnosis of atrophic gastritis].
    Pimenov SI; Makarenko EV
    Ter Arkh; 2008; 80(2):15-21. PubMed ID: 18372589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais.
    Yamada S; Matsuhisa T; Makonkawkeyoon L; Chaidatch S; Kato S; Matsukura N
    J Gastroenterol; 2006 Dec; 41(12):1169-77. PubMed ID: 17287896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.